Skip to main content
. 2020 Mar 21;14(4):377–387. doi: 10.1007/s12079-020-00558-3

Fig. 2.

Fig. 2

CUDC-907 inhibits cell viability in human breast cancer cells. Cell Counting Kit-8 assay of breast cancer cells treated with increasing dose of CUDC-907 for 24 h. Mean ± SD, n = 3. *indicates that P < 0.05 and **indicates that P < 0.01 versus control group (0 nM CUDC-907)